Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: Is time really the major determinant?

Internal and Emergency Medicine

Volumn 8, Issue 2, 2013, Pages 129-139

  Giglioli, Cristina ^a   Cecchi, Emanuele ^a   Landi, Daniele ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Romano, Salvatore Mario ^a   Spini, Valentina ^a   Perrotta, Laura ^a   Simonetti, Ignazio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Early invasive strategy; Prognosis; Timing of angiography

Indexed keywords

EID: 84874378794     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0596-5     Document Type: Article

References (41)

1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr., Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50: e1-e157.
2. Task Force Members, Bassand J-P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KAA, Hasdai D, Magnus Ohman E, Wallentin L, Wijns W, ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, DalbyKristensen S, Widimsky P, McGregor K, Sechtem U, Tendera M, Hellemans I, Gomez JLZ, Silber S, Funck-Brentano C, Document Reviewers, DalbyKristensen S, Andreotti F, Benzer W, Bertrand M, Betriu A, De Caterina R, DeSutter J, Falk V, Ortiz AF, Gitt A, Hasin Y, Huber K, Kornowski R, Lopez-Sendon J, Morais J, Erik Nordrehaug J, Silber S, Steg PG, Thygesen K, Tubaro M, Turpie AGG, Verheugt F, Windecker S (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 28: 1598-1660.
3. Lagerqvist B, Husted S, Kontny F, Ståhle E, Swahn E, Wallentin L (2006) Fast Revascularisation during InStability in Coronary artery disease (FRISC-II) Investigators. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 368: 998-1004.
4. Fox K, Poole-Wilson P, Clayton T, Henderson R, Shaw T, Wheatley D, Knight R, Pocock S (2005) 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 366: 914-920.
5. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E (2001) TACTICS (Treat Angina with Aggrastat, Determine Cost of Therapy with an Invasive or Conservative Strategy)-thrombolysis in myocardial infarction 18 investigators comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344: 1879-1887.
6. Spacek R, Widimský P, Straka Z, Jiresová E, Dvorák J, Polásek R, Karel I, Jirmár R, Lisa L, Budesínský T, Málek F, Stanka P (2002) Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J 23: 230-238.
7. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S (2005) Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 293: 2908-2917.
8. Bavry AA, Kumbhani DJ, Bhatt DL, Rassi AN, Askari AT (2006) Benefit of early invasive therapy in acute coronary syndromes. A meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 48: 1319-1325.
9. Tricoci P, Lokhnygina Y, Berdan LG, Steinhubl SR, Gulba DC, White HD, Kleiman NS, Aylward PE, Langer A, Califf RM, Ferguson JJ, Antman EM, Newby LK, Harrington RA, Goodman SG, Mahaffey KW (2007) Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation 116: 2669-2677.
10. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102: 2031-2037.
11. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction (2007)Universal definition of myocardial infarction. Circulation 116: 2634-2653.
12. Nieto FJ, Coresh J (1996) Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol 143: 1058-1068.
13. DeWood MA, Stifter WF, Simpson CS, Spores J, Eugster GS, Judge TP, Hinnen ML (1986) Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 315: 417-423.
14. Braunwald E (1998) Unstable angina: an etiologic approach to management. Circulation 98: 2219-2222.
15. Prasad A, Mathew V, Holmes DRJr, Gersh BJ (2003) Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. Eur Heart J 24: 1544-1553.
16. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S, TIMACS Investigators (2009) Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360: 2165-2175.
17. Katritsis DG, Siontis GC, Kastrati A, van't Hof AW, Neumann FJ, Siontis KC, Ioannidis JP (2011) Optimal timing of coronary angiography and potential intervention in non-ST- elevation acute coronary syndromes. Eur Heart J 32: 32-40.
18. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, Schmitt C, Seyfarth M, Dirschinger J, Schömig A (2003) Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 290: 1593-1599.
19. Luchi RJ, Scott SM, Deupree RH (1987) Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J 316: 977-984.
20. Takaro T, Hultgren HN, Lipton MJ, Detre KM (1976)The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 54(6 Suppl): III107-III117.
21. Antman EM, Transijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fisher GA, Fung AY, Thompson C, Wybega D, Braunwald E (1996) Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335: 1342-1349.
22. Henrikson CA, Howell EE, Bush DE, Miles JS, Meininger GR, Friedlander T, Bushnell AC, Chandra-Strobos N (2004) Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 93: 275-279.
23. Nageh T, Sherwood R, Harris BM, Byrne JAQ, Thomas MR (2003) Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 92: 285-293.
24. Bertnchant JP, Polge A, Ledermamnn B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J (1999) Relation of minor cardiac Troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 84: 51-57.
25. Riccirdi MJ, Davidson CJ, Gubernikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO (2003) Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 145: 522-528.
26. Bolognese L, Falsini G, Liistro F, Angioli P (2005) Myocardial damage during percutaneous interventions for non-ST-elevation acute coronary syndromes. Eur Heart J 7(Suppl. K): K15-K18.
27. Bolognese L, Ducci K, Angioli P, Falsini G, Liistro F, Baldassarre S, Burali A (2004) Elevations in Troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high risk patients with non-ST segment elevation acute coronary syndromes. Circulation 110: 1592-1597.
28. Simoons ML, GUSTO IV-ACS Investigators (2001) Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet 357: 1915-1924.
29. Brosius FC 3rd, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, Pennathur S, Smith GL, Wilson PW; American Heart Association Kidney and Cardiovascular Disease Council; Council on High Blood Pressure Research; Council on Cardiovascular Disease in the Young; Council on Epidemiology and Prevention; Quality of Care and Outcomes Research Interdisciplinary Working Group (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114: 1083-1087.
30. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295.
31. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA, GRACE Investigators (2004) A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291: 2727-2733.
32. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP, GRACE Investigators (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149: 67-73.
33. Wilcox I, Freedman SB, Allman KC, Collins FL, Leitch JW, Kelly DT, Harris PJ (1991) Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 18: 677-683.
34. Karlson BW, Herlitz J, Pettersson P, Hallgren P, Strömbom U, Hjalmarson A (1993) One-year prognosis in patients hospitalized with a history of unstable angina pectoris. ClinCardiol 16: 397-402.
35. Fava S, Azzopardi J, Agius-Muscat H (1997) Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 14: 209-213.
36. García-Rubira JC, Cruz JM, López V, Plaza L, Navas JC (1994) Outcome of patients with diabetes and unstable angina. A subgroup analysis in the Spanish Multicentre Trial of trifusal in unstable angina. Grupo de Estudio del Trifusal en la Angina Inestable. Int J Cardiol 46: 175-178.
37. von Beckerath N, Taubert D, Pogatsa-Murray G, Schomig E, Kastrati A, Schomig A (2005) Absorption, metabolization, and antiplateleteffects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) trial. Circulation 112: 2946-2950.
38. Lincoff AM, Kleiman NS, Kereiakes DJ, Feit F, Bittl JA, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ, REPLACE-2 Investigators (2004) Long-termefficacy of bivalirudin and provisional glycoproteinIIb/IIIablockade vs heparin and plannedglycoproteinIIb/IIIablockadeduringpercutaneouscoronaryrevascularization: REPLACE-2 randomized trial. JAMA 292: 696-703.
39. White H (2001) Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 358: 1855-1863.
40. Brener SJ, Milford-Beland S, Roe MT, Bhatt DL, Weintraub WS, Brindis RG (2008) Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report. Am Heart J 155: 140-146.
41. Shishehbor MH, Lauer MS, Singh IM, Chew DP, Karha J, Brener SJ, Moliterno DJ, Ellis SG, Topol EJ, Bhatt DL (2007) In unstable angina or non-ST segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting. J Am Coll Cardiol 49: 849-854.